Clinical Trials
28 trialsOPTICS
DL Analytics
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
UNC Lineberger Comprehensive Cancer Center
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
AIDS Malignancy Consortium
Confocal
British Columbia Cancer Agency
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Activating Collaborative CIS Support Via Targeted Provider Mailing
Northwestern University
MDC_Algo
British Columbia Cancer Agency
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
GlaxoSmithKline
Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
M.D. Anderson Cancer Center
Fenretinide in Treating Patients With Cervical Neoplasia
M.D. Anderson Cancer Center
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
Albert Einstein College of Medicine
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
University of California, San Francisco
Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer
Wake Forest University Health Sciences
Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia
British Columbia Cancer Agency
SAGE
British Columbia Cancer Agency
Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
Alliance for Clinical Trials in Oncology
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
University of Alabama at Birmingham
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer
GOG Foundation
Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear
British Columbia Cancer Agency
Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer
University of Washington
SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Diindolylmethane in Treating Patients With Abnormal Cervical Cells
National Cancer Institute (NCI)
Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears
M.D. Anderson Cancer Center
Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix
British Columbia Cancer Agency
Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171
National Cancer Institute (NCI)
IRB 1996-0189
University of Michigan Rogel Cancer Center
Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy
National Cancer Institute (NCI)